Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The investigators want to find out whether a recently introduced combination of two blood
pressure lowering agents (olmesartan and amlodipine) has a different blood pressure lowering
effect than a single active substance. In addition the investigators want to find out whether
there is a difference in the changes in blood pressure over the course of a day depending on
the time when the medications are taken (in the morning or at night). Male and female
patients over 18 years of age may participate.